Molecular Diagnostics for Cancer Drug Development June 27, 2011

Presented by Hanson Wade, the Molecular Diagnostics for Cancer Drug Development will discuss the latest approaches for stratifying patient populations with molecular diagnostics and will address how to increase your oncology drug program’s chance of success. The event will also provide an overview of the latest FDA guidance and regulation for CDx development and approval.

Steve Coats will present on the topic of "Targeted Therapies in Cancer."

MedImmune is a sponsor.